Home › Risk-Taking › NCT07320664
Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women
RecruitingHealthy volunteers welcome
Alcohol Counter Marketing as a Breast Cancer Prevention Strategy in Young Women
Who can join
Ages 18 to 25 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Assigned female at birth. * Age 18-25 at enrollment. * Report drinking alcohol at least once in the past 30 days. * Not pregnant or intending to become pregnant by self-report. * Reside in Ohio, Michigan, Illinois, Wisconsin, or New Jersey. * Willing to complete procedures. * Able to complete procedures a, b, or c: 1. Can read, write, and converse in English. 2. Has a personal mobile smartphone with texting capabilities to receive text messages that may contain text and images. 3. For the subsample who will wear the BACTrack sensor, they must have an iPhone. At the time of this protocol, the BACTrack skyn app is only compatible with iPhones. If this expands to Android phones over the course of the study, Android phones will be eligible. Exclusion Criteria: * Assigned male at birth * Ages \<18 or \>25 at enrollment * Do not report drinking alcohol at least once in the past 30 days * Pregnant or intending to become pregnant by self-report. * Do not reside in Ohio, Michigan, Illinois, Wisconsin, or New Jersey. * Not willing to complete procedures. * Unable to complete procedures.
About the study
This randomized trial aims to test the effects of co-created breast cancer counter marketing intervention messages for reducing alcohol consumption and impacting awareness and beliefs about the breast cancer risks from alcohol consumption in young adult women.
What is being tested
- Alcohol and Breast Cancer Risk Messages (behavioral)
- Skin Cancer Risk Messages (behavioral)
Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 500 · Started: Mar 19, 2026
Contact the study team
- The Ohio State University Comprehensive Cancer Center · Phone: 800-293-5066
Official record on ClinicalTrials.gov — NCT07320664
Locations in the U.S.
| Ohio | Ohio State University Comprehensive Cancer Center, Columbus |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.